Bosutinib

Red

Brand Name(s):Bosulif

Indication:Myeloid leukaemia (chronic)
Chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia

Rationale:1,2,3

Considered:Aug-16

Review Date:Jun-23

Comments:
NICE TA401
Bosutinib for previously treated chronic myeloid leukaemia
August 2016